{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:31:26Z","timestamp":1792477886319,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.pharmthera.2013.12.008","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T07:01:56Z","timestamp":1386831716000},"page":"231-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Improving cardiovascular outcomes in rheumatic diseases: Therapeutic potential of circulating endothelial progenitor cells"],"prefix":"10.1016","volume":"142","author":[{"given":"John A.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail C.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian N.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Yvonne","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2013.12.008_bb0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00296-010-1377-6","article-title":"Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE","volume":"31","author":"Ablin","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/rheumatology\/kem002","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype","volume":"46","author":"Ahmad","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.0000154789.28695.ea","article-title":"Mobilizing endothelial progenitor cells","volume":"45","author":"Aicher","year":"2005","journal-title":"Hypertension"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2013.12.008_bb0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2482-12-S1-S1","article-title":"Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis","volume":"12","author":"Amato","year":"2012","journal-title":"BMC Surg"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0025","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jor.22097","article-title":"Differential analysis of peripheral blood- and bone marrow-derived endothelial progenitor cells for enhanced vascularization in bone tissue engineering","volume":"30","author":"Amini","year":"2012","journal-title":"J Orthop Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nprot.2010.6","article-title":"In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract","volume":"5","author":"Arnaoutova","year":"2010","journal-title":"Nat Protocol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0035","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0040","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0045","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/ard.2007.082131","article-title":"Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.HYP.0000159191.98140.89","article-title":"Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists","volume":"45","author":"Bahlmann","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00296-010-1730-9","article-title":"Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification","volume":"32","author":"Baker","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0060","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s12015-011-9321-z","article-title":"Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial","volume":"8","author":"Baran","year":"2012","journal-title":"Stem Cell Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2013.12.008_bb0065","first-page":"10","article-title":"Circulating and tissue resident endothelial progenitor cells","volume":"229","author":"Basile","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0070","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/blood-2003-08-2770","article-title":"Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells","volume":"103","author":"Bompais","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1179\/1743132811Y.0000000038","article-title":"Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients","volume":"33","author":"Brea","year":"2011","journal-title":"Neurol Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0080","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1096\/fj.09-138198","article-title":"Correlations between progression of coronary artery disease and circulating endothelial progenitor cells","volume":"24","author":"Briguori","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0085","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000095788.78169.AF","article-title":"Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging","volume":"108","author":"Britten","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0090","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kei142","article-title":"\u2018Not only\u2026but also\u2019: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus","volume":"44","author":"Bruce","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0095","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study","volume":"48","author":"Bruce","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00228-011-1029-0","article-title":"Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients","volume":"67","author":"Cacciatore","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11589400-000000000-00000","article-title":"ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes","volume":"11","author":"Cangiano","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/039463201002300123","article-title":"Long-term anti-TNF-alpha treatments reverse the endothelial dysfunction in rheumatoid arthritis: the biological coherence between synovial and endothelial inflammation","volume":"23","author":"Capria","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-010-9383-8","article-title":"Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients","volume":"38","author":"Chen","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejphar.2011.02.044","article-title":"Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes","volume":"659","author":"Chen","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2184.2011.00764.x","article-title":"Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood","volume":"44","author":"Chen","year":"2011","journal-title":"Cell Prolif"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0961203306071870","article-title":"Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus","volume":"15","author":"Chung","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0135","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jss.2008.07.017","article-title":"Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization","volume":"157","author":"Coppolino","year":"2009","journal-title":"J Surg Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/08037051.2010.535973","article-title":"Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension","volume":"20","author":"de Ciuceis","year":"2011","journal-title":"Blood Press"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004872-200501000-00004","article-title":"Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Deanfield","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/FJC.0b013e3181a7b572","article-title":"Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction","volume":"53","author":"Dedobbeleer","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0155","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00296-009-1156-4","article-title":"Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage","volume":"30","author":"Deng","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0160","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-{alpha} promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0165","doi-asserted-by":"crossref","first-page":"585018","DOI":"10.1155\/2012\/585018","article-title":"Dysfunctional endothelial progenitor cells in metabolic syndrome","volume":"2012","author":"Devaraj","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ghir.2007.11.001","article-title":"Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults","volume":"18","author":"Devin","year":"2008","journal-title":"Growth Hormon IGF Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1160\/TH07-08-0509","article-title":"The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia","volume":"100","author":"Di","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1515\/cclm-2011-0670","article-title":"Effects of endothelin-1 on endothelial progenitor cell function","volume":"50","author":"Diehl","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2008.091918","article-title":"EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells","volume":"68","author":"Distler","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2012.02.002","article-title":"The effect of tumor necrosis factor-alpha antagonists on arterial stiffness in rheumatoid arthritis: a literature review","volume":"42","author":"Dulai","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/rheumatology\/kep335","article-title":"Accumulation of VEGFR-2+\/CD133+ cells and decreased number and impaired functionality of CD34+\/VEGFR-2+ cells in patients with SLE","volume":"49","author":"Ebner","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0200","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/rheumatology\/ken299","article-title":"Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics","volume":"47","author":"Egan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0205","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000136807.78534.50","article-title":"Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women","volume":"110","author":"El-Magadmi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0210","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2005-06-2307","article-title":"CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood","volume":"106","author":"Elshal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0215","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1463-1326.2011.01367.x","article-title":"Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes\u2014a randomized controlled trial","volume":"13","author":"Esposito","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0225","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/ten.2006.12.331","article-title":"Comparative analysis of methods for assessment of circulating endothelial progenitor cells","volume":"12","author":"George","year":"2006","journal-title":"Tissue Eng"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0235","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases","volume":"26","author":"Goules","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","article-title":"Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis","volume":"111","author":"Grisar","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0250","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/rheumatology\/ken286","article-title":"Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells","volume":"47","author":"Grisar","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0255","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/ard.2006.066605","article-title":"Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy","volume":"66","author":"Grisar","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","article-title":"Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis","volume":"111","author":"Grisar","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0265","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jacc.2006.04.101","article-title":"The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease","volume":"48","author":"Guven","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0270","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2668","article-title":"Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis","volume":"11","author":"Hannawi","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2005.035378","article-title":"Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells","volume":"65","author":"Herbrig","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0280","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/ATVBAHA.107.155960","article-title":"Assessing identity, phenotype, and fate of endothelial progenitor cells","volume":"28","author":"Hirschi","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0285","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/03009742.2011.585350","article-title":"Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients","volume":"40","author":"Hjeltnes","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0290","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/rheumatology\/31.11.725","article-title":"Cytokine inter-relationships and their association with disease activity in arthritis","volume":"31","author":"Holt","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0295","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2006.05.031","article-title":"Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment","volume":"192","author":"Hristov","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0300","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCULATIONAHA.109.862771","article-title":"Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury","volume":"121","author":"Hristov","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0310","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Antitumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0315","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2005-04-1509","article-title":"Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells","volume":"106","author":"Ingram","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0320","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/ar2934","article-title":"Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity","volume":"12","author":"Jodon de Villeroche","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0325","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.50.7.526-c","article-title":"Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus","volume":"50","author":"Julkunen","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0330","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.1101284","article-title":"Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus","volume":"187","author":"Kahlenberg","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0335","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3727\/096368911X627499","article-title":"Cotreatment with darbepoetin and granulocyte colony-stimulating factor is efficient to recruit proangiogenic cell populations in patients with acute myocardial infarction","volume":"21","author":"Kang","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ccd.20406","article-title":"Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium","volume":"65","author":"Katritsis","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0345","first-page":"398","article-title":"Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity","volume":"35","author":"Kerekes","year":"2008","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.pharmthera.2013.12.008_bb0350","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/art.37997","article-title":"Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress","volume":"68","author":"Kim","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaut.2006.09.008","article-title":"Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients","volume":"27","author":"Kiss","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0360","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1582-4934.2008.00479.x","article-title":"CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro","volume":"13","author":"Krenning","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0365","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/art.10269","article-title":"Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis","volume":"46","author":"Kumeda","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0370","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0375","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2011-200713","article-title":"Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols","volume":"71","author":"Kuwana","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0380","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jtcvs.2011.08.053","article-title":"Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product","volume":"144","author":"Lasala","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1445-5994.2006.01044.x","article-title":"Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus","volume":"36","author":"Lee","year":"2006","journal-title":"Intern Med J"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0390","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0395","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2008.05.036","article-title":"Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial","volume":"130","author":"Leone","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0400","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0609.2007.01007.x","article-title":"Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease","volume":"80","author":"Liguori","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0405","first-page":"292","article-title":"Brachial endothelial function is impaired in patients with systemic lupus erythematosus","volume":"29","author":"Lima","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0410","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI8071","article-title":"Origins of circulating endothelial cells and endothelial outgrowth from blood","volume":"105","author":"Lin","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0415","doi-asserted-by":"crossref","first-page":"e50739","DOI":"10.1371\/journal.pone.0050739","article-title":"Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization","volume":"7","author":"Ling","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0420","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MAJ.0b013e31824998f9","article-title":"Beneficial effects of statins on endothelial progenitor cells","volume":"344","author":"Liu","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0425","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/10428190009065835","article-title":"Decrease of circulating hematopoietic progenitor cells During interleukin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion","volume":"39","author":"Locker","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0430","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1213\/ANE.0b013e3181b5a277","article-title":"Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics","volume":"109","author":"Lucchinetti","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0435","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1476-5381.2011.01423.x","article-title":"Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells","volume":"164","author":"Mangialardi","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0440","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0445","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/ard.2010.148031","article-title":"Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis","volume":"70","author":"Marder","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0450","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0008-6363(02)00785-X","article-title":"Post-natal endothelial progenitor cells for neovascularization in tissue regeneration","volume":"58","author":"Masuda","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2169\/internalmedicine.47.0284","article-title":"The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease","volume":"47","author":"Matsuo","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0460","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/anr.1780320206","article-title":"Tumor necrosis factor in the serum of patients with systemic lupus erythematosus","volume":"32","author":"Maury","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0465","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/1087057112454919","article-title":"Circulating proangiogenic cell activity is associated with cardiovascular disease risk","volume":"17","author":"Mavromatis","year":"2012","journal-title":"J Biomol Screen"},{"issue":"9\u201310","key":"10.1016\/j.pharmthera.2013.12.008_bb0470","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2119\/molmed.2011.00129","article-title":"Myeloid angiogenic cells (MACs) act as alternative M2 macrophages and modulate angiogenesis through IL-8","volume":"17","author":"Medina","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0475","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-3-18","article-title":"Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities","volume":"3","author":"Medina","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0480","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/ard.2010.144485","article-title":"Safety profile and clinical activity of sifalimumab, a fully human anti-interferon alpha monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study","volume":"70","author":"Merrill","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0485","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1253\/circj.CJ-11-1499","article-title":"Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease","volume":"76","author":"Moon","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0490","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar2283","article-title":"Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus","volume":"9","author":"Moonen","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0495","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/j.bbagen.2012.12.014","article-title":"Proteomic characterization of EPCs and CECs \u201cin vivo\u201d from acute coronary syndrome patients and control subjects","volume":"1830","author":"Mourino-Alvarez","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0500","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/hrt.2010.220798","article-title":"Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease","volume":"97","author":"Mueller","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0505","first-page":"CR616","article-title":"Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis","volume":"8","author":"Pache","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0510","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/heartjnl-2012-302949","article-title":"Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease","volume":"99","author":"Padfield","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0515","first-page":"153","article-title":"Effect of pravastatin on endothelial function and endothelial progenitor cells in healthy postmenopausal women","volume":"39","author":"Paradisi","year":"2012","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0520","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.37824","article-title":"Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study","volume":"65","author":"Petri","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0525","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2796.2011.02510.x","article-title":"Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment","volume":"272","author":"Pirro","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0530","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248408331021","article-title":"Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function","volume":"14","author":"Pirro","year":"2009","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pharmthera.2013.12.008_bb0535","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.amjcard.2013.04.056","article-title":"Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"112","author":"Porto","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0540","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.ATV.0000151690.43777.e4","article-title":"Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease","volume":"25","author":"Powell","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0545","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood-2009-02-205930","article-title":"Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures","volume":"114","author":"Prokopi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0550","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","article-title":"Peripheral blood \u201cendothelial progenitor cells\u201d are derived from monocyte\/macrophages and secrete angiogenic growth factors","volume":"107","author":"Rehman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0555","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0961203308097572","article-title":"Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus","volume":"18","author":"Robak","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0560","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/kes152","article-title":"Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients","volume":"51","author":"Rodriguez-Carrio","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0565","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-144-4-200602210-00006","article-title":"Preclinical carotid atherosclerosis in patients with rheumatoid arthritis","volume":"144","author":"Roman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0570","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0575","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2004.08.014","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial","volume":"44","author":"Scachinger","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0580","doi-asserted-by":"crossref","first-page":"e13790","DOI":"10.1371\/journal.pone.0013790","article-title":"Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol","volume":"5","author":"Schmidt-Lucke","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0585","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/CS20100429","article-title":"Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease","volume":"120","author":"Sen","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0590","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/03009740801910320","volume":"37","author":"Sennels","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0595","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2006.09.050","article-title":"Endothelial progenitor cells in cardiovascular disorders","volume":"49","author":"Shantsila","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0600","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2007.09.059","article-title":"Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay","volume":"51","author":"Sieveking","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0605","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","article-title":"From endothelial dysfunction to atherosclerosis","volume":"9","author":"Sitia","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0610","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1468-1331.2012.03770.x","article-title":"Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase","volume":"19","author":"Sobrino","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0615","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1161\/STROKEAHA.107.484386","article-title":"The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome","volume":"38","author":"Sobrino","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0620","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1196\/annals.1361.068","article-title":"Plasminogen Activator Inhibitor-1 Is Associated with Impaired Endothelial Function in Women with Systemic Lupus Erythematosus","volume":"1051","author":"Somers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0625","doi-asserted-by":"crossref","first-page":"e37000","DOI":"10.1371\/journal.pone.0037000","article-title":"Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients","volume":"7","author":"Somers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0630","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/HYPERTENSIONAHA.108.111914","article-title":"Nifedipine improves endothelial function: role of endothelial progenitor cells","volume":"52","author":"Sugiura","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0635","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.22424","article-title":"Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis","volume":"56","author":"Surdacki","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0640","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ahj.2009.12.021","article-title":"Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction","volume":"159","author":"Taljaard","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0645","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-{alpha} on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0650","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/ars.2010.3503","article-title":"Organic nitrates differentially modulate circulating endothelial progenitor cells and endothelial function in patients with symptomatic coronary artery disease","volume":"15","author":"Thum","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0655","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3069","article-title":"Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion","volume":"12","author":"Tinazzi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0660","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ijo.2009.280","article-title":"Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity","volume":"34","author":"Tobler","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0665","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.atherosclerosis.2011.08.045","article-title":"The association between circulating endothelial progenitor cells and coronary collateral formation","volume":"219","author":"Tokgozoglu","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0670","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1538-7836.2010.03900.x","article-title":"Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy","volume":"8","author":"Tura","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0675","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/stem.1280","article-title":"Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow","volume":"31","author":"Tura","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0680","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J","article-title":"Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera","volume":"42","author":"Vakkalanka","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0685","first-page":"827","article-title":"Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis","volume":"26","author":"Valdivielso","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0690","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jim.2007.12.006","article-title":"Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches","volume":"332","author":"Van Craenenbroeck","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0695","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0700","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.RES.0000193596.94936.2c","article-title":"Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease","volume":"97","author":"Walter","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0705","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2796.2009.02123.x","article-title":"Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis","volume":"266","author":"Wang","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0710","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/mt.2011.52","article-title":"Nitric oxide synthase gene transfer restores activity of circulating angiogenic cells from patients with coronary artery disease","volume":"19","author":"Ward","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0715","first-page":"1196","article-title":"All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database","volume":"30","author":"Watson","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0720","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0725","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/ard.2006.065631","article-title":"Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus","volume":"66","author":"Westerweel","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0730","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/rheumatology\/ken494","article-title":"Comment on: systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells","volume":"48","author":"Westerweel","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0735","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/acel.12031","article-title":"Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans","volume":"12","author":"Williamson","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0740","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1161\/01.ATV.0000238351.82900.7f","article-title":"Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus","volume":"26","author":"Wright","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0745","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1371\/journal.pone.0000975","article-title":"Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis\u2014results from a large population-based study","volume":"2","author":"Xiao","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0750","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00246-011-9900-4","article-title":"The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease","volume":"32","author":"Xu","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0755","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.CIR.0000055313.77510.22","article-title":"Stromal cell\u2212derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization","volume":"107","author":"Yamaguchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0760","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/STROKEAHA.107.489401","article-title":"Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke","volume":"39","author":"Yip","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0765","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3899\/jrheum.090782","article-title":"Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification","volume":"37","author":"Yiu","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0770","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","volume":"109","author":"Yoder","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0775","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/ard.54.5.361","article-title":"Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus","volume":"54","author":"Yoshio","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0780","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.amjcard.2010.06.045","article-title":"Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease","volume":"106","author":"Yue","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.12.008_bb0785","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.cr.7310075","article-title":"Adult endothelial progenitor cells from human peripheral blood maintain monocyte\/macrophage function throughout in vitro culture","volume":"16","author":"Zhang","year":"2006","journal-title":"Cell Res"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T20:39:28Z","timestamp":1564951168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725813002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":157,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0163725813002477"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving cardiovascular outcomes in rheumatic diseases: Therapeutic potential of circulating endothelial progenitor cells","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}